Papillomavirus infection in rural women in southern India.

PubWeight™: 1.79‹?› | Rank: Top 3%

🔗 View Article (PMC 2362069)

Published in Br J Cancer on February 14, 2005

Authors

S Franceschi1, R Rajkumar, P J F Snijders, A Arslan, C Mahé, M Plummer, R Sankaranarayanan, J Cherian, C J L M Meijer, E Weiderpass

Author Affiliations

1: International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France. franceschi@iarc.fr

Articles citing this

Do cervical cancer data justify HPV vaccination in India? Epidemiological data sources and comprehensiveness. J R Soc Med (2012) 3.18

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83

Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis (2005) 1.65

Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62

HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer (2009) 1.50

The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategies. Int J Cancer (2011) 1.38

Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studies. Int J Cancer (2012) 1.32

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India. Br J Cancer (2008) 1.30

Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer (2010) 1.10

Detection of human papillomavirus in women attending Pap cervical screening camp at a peripheral hospital of North-Eastern India. Med J Armed Forces India (2013) 1.05

Epidemiology of cervical cancer with special focus on India. Int J Womens Health (2015) 0.99

Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer (2008) 0.96

Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis (2014) 0.95

Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial. Int J Cancer (2014) 0.92

Difference in overall and age-specific prevalence of high-risk human papillomavirus infection in Italy: evidence from NTCC trial. BMC Infect Dis (2013) 0.90

Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int J Gynecol Pathol (2008) 0.87

Oncogenic HPV among HIV infected female population in West Bengal, India. BMC Infect Dis (2011) 0.86

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer (2006) 0.84

Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations. PLoS One (2013) 0.78

Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis (2016) 0.77

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior. Emerg Infect Dis (2016) 0.75

Monitoring HPV16/18 immunisation in England and elsewhere. Br J Cancer (2010) 0.75

Prevalence of Human Papilloma Virus Infection in Young Primiparous Women During Postpartum Period: Study from a Tertiary Care Center in Northern India. J Clin Diagn Res (2016) 0.75

Pre-vaccine era cervical human papillomavirus infection among screening population of women in west Austria. BMC Public Health (2016) 0.75

Articles cited by this

Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer (2004) 3.03

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33

Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25

Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis (2003) 1.93

Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer (2003) 1.77

Human papillomavirus infection among women in South and North Vietnam. Int J Cancer (2003) 1.71

Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer (2003) 1.71

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55

Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer (2005) 1.40

Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis (2003) 1.33

Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer (2004) 1.29

Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes Control (2000) 1.09

Are Muslim women less susceptible to oncogenic human papillomavirus infection? A study from rural eastern India. Int J Gynecol Cancer (2004) 1.01

Articles by these authors

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer (2003) 8.01

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet (2005) 7.09

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet (2007) 5.81

Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85

Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ (2001) 4.28

Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81

Trends in cancer incidence and mortality. IARC Sci Publ (1993) 3.19

Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene (2006) 2.56

Seasonal variation of blood pressure and its relationship to ambient temperature in an elderly population. J Hypertens (1993) 2.40

Chapter 8: Screening for cervical cancer in developing countries. Vaccine (2006) 2.35

Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27

Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25

Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14

Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J Intern Med (2007) 2.12

Venous thromboembolism and cancer. Lancet (1998) 2.08

Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell (2000) 2.05

Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05

Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol (2006) 2.02

Preventing excessive weight gain during pregnancy - a controlled trial in primary health care. Eur J Clin Nutr (2007) 1.91

Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer (2004) 1.88

Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83

Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer (1999) 1.83

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

Trends in cancer incidence in Chennai city (1982-2006) and statewide predictions of future burden in Tamil Nadu (2007-16). Natl Med J India (2011) 1.81

Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol (2013) 1.77

Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev (2000) 1.76

Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer (2007) 1.76

[Longitudinal study of the mother and child population in an urban region of southern Brazil, 1993: methodological aspects and preliminary results]. Rev Saude Publica (1996) 1.74

Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Int J Gynaecol Obstet (2005) 1.73

Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68

Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab (1999) 1.67

Magnification and chromoscopy with the acetic acid test. Endoscopy (2003) 1.67

Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol (2005) 1.64

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol (2004) 1.63

Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol (2004) 1.63

Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62

Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59

Cigarette smoking, alcohol consumption, and risk of hip fracture in women. Arch Intern Med (2001) 1.59

Fournier's gangrene and its emergency management. Postgrad Med J (2006) 1.56

Occupational exposures and pancreatic cancer: a meta-analysis. Occup Environ Med (2000) 1.56

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55

Cancer incidence in Karachi, Pakistan: first results from Karachi Cancer Registry. Int J Cancer (2000) 1.55

Prevalence and trends of sunscreen use and sunburn among Norwegian women. Br J Dermatol (2014) 1.54

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer (2012) 1.53

Cytokinin induced shoot regeneration and flowering of Scoparia dulcis L. (Scrophulariaceae)-an ethnomedicinal herb. Asian Pac J Trop Biomed (2011) 1.50

C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest (2004) 1.50

HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer (2009) 1.50

Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol (2011) 1.47

Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res (2011) 1.47

Cancer deaths in India: is the model-based approach valid? Bull World Health Organ (1994) 1.46

Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma. J Pathol (2006) 1.46

Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br J Cancer (2006) 1.43

A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol (2004) 1.43

Collaboration between developing and developed countries and between developing countries in occupational health research and surveillance. Scand J Work Environ Health (1999) 1.41

Environmental risk factors of breast cancer. Scand J Work Environ Health (1998) 1.40

Pacifier use and short breastfeeding duration: cause, consequence, or coincidence? Pediatrics (1997) 1.39

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol (2002) 1.36

Alcohol abuse and the risk of pancreatic cancer. Gut (2002) 1.35

Validation of high-risk HPV tests for primary cervical screening. J Clin Virol (2009) 1.35

Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ (2005) 1.35

[Vaccines against human papillomavirus (HPV); between registration and implementation]. Ned Tijdschr Geneeskd (2008) 1.34

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer (2012) 1.34

Population-based cancer survival in Singapore, 1968 to 1992: an overview. Int J Cancer (2001) 1.33

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer (2007) 1.32

[Flat penile lesions in the sexual transmission of human papillomavirus]. Ned Tijdschr Geneeskd (2008) 1.32

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J Clin Pathol (2005) 1.31

Trimester-specific reference intervals for thyroxine and triiodothyronine in pregnancy in iodine-sufficient women using isotope dilution tandem mass spectrometry and immunoassays. Clin Chim Acta (2004) 1.30

Cervical cancer screening: on the way to a shift from cytology to full molecular screening. Ann Oncol (2014) 1.30

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control (1999) 1.28

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC. J Pathol (2008) 1.28

Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece. Histopathology (2006) 1.28

The sexual health of pupils in years 4 to 6 of primary schools in rural Tanzania. Sex Transm Infect (2004) 1.27

An introduction to epidemiological research with medical databases. Ann Epidemiol (2000) 1.27